Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Halil Göksel Güzel
Observed names:
Güzel, Halil Göksel,
H.G. Güzel,
Halil G. Güzel,
Halil Goksel Guzel,
Halil Göksel GÜZEL,
Halil Güzel
show all 6
Institutions:
Antalya Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Antalya Şehi̇r Hastanesi̇
Observed institutions:
Akdeniz University,
Antalya Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Antalya Şehi̇r Hastanesi̇
ORCID:
0000-0001-8310-1752
Observed ORCID:
0000-0001-8310-1752
OpenAlex ID:
A5085364414
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
2023
·
Çağlar Ünal
, Abdulmunir Azizy
, et al.
·
The Oncologist
·
11
PDF
Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study
2025
·
Taha Koray Sahin
, Fatih Atalah
, et al.
·
Frontiers in Immunology
·
4
PDF
Novel tumor marker index combining carcinoembryonic antigen and carbohydrate antigen 19-9: New prognostic factor for metastatic colorectal cancer
2025
·
Yusuf Ilhan
, Onur Yazdan Balcik
, et al.
·
World Journal of Gastrointestinal Oncology
·
4
PDF
Rectal Cancer in Young Adults: A Single Center Experience
2024
·
Halil Göksel Güzel
, Murat Koçer
, et al.
·
Journal of Adolescent and Young Adult Oncology
·
4
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma
2024
·
Hasan Cagri Yildirim
, Ertuğrul Bayram
, et al.
·
Journal of Chemotherapy
·
4
Tyrosine kinase inhibitor-induced immune hemolytic anemia; three different drugs in three separate cases
2023
·
Halil Göksel Güzel
, Derya Kıvrak Salim
·
Journal of Oncology Pharmacy Practice
·
3
PDF
Prognostic role of smoking in metastatic renal cell carcinoma in real-world data from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)
2026
·
Hatice Bolek
, Elif Sertesen Camoz
, et al.
·
Scientific Reports
·
2
PDF
Prognostic Factors and Survival Data of Stage I Lung Cancer: A Single-Center Experience
2025
·
Mustafa Ozgur Arici
, Halil Goksel Guzel
, et al.
·
Journal of Clinical Practice and Research
·
2
PDF
Real‐world comparison of cabozantinib and sunitinib in advanced non‐clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group
2025
·
Gökhan Şahin
, Esmanur Kaplan Tüzün
, et al.
·
International Journal of Cancer
·
2
Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach
2025
·
Hakan Şat Bozcuk
, Leyla Sert
, et al.
·
Cancers
·
2
PDF
Evaluation of the predictive and prognostic performance of the PILE score in metastatic renal cell carcinoma
2026
·
Halil Göksel Güzel
, Asım Armağan Aydın
, et al.
·
Frontiers in Medicine
·
1
PDF
Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish Oncology Group Kidney Cancer Consortium (TKCC) Study
2026
·
Murat Günaltılı
, Hatice Bölek
, et al.
·
Cancers
·
1
Is the risk of brain metastasis and prognosis different in HER2-low breast cancer?
2025
·
Yaşar Culha
, Beyza Ünlü
, et al.
·
Clinical & Translational Oncology
·
1
Symptom Reporting Behaviors, Symptom Burden, and Quality of Life in Patients with Hormone Receptor–Positive Breast Cancer Undergoing Adjuvant Endocrine Therapy
2025
·
Ece Ulukal Karanci
, Halil Göksel Güzel
, et al.
·
Current Oncology
·
1
PDF
Rethinking Neoadjuvant Therapy: A Critical Evaluation of Exclusion Criteria in Gastric Cancer Surgery Studies
2025
·
Yusuf Ilhan
, Halil Goksel Guzel
, et al.
·
Journal of the Korean Gastric Cancer Association
·
1
PDF
Reshaping the landscape of ovarian cancer: implications from the surgery for ovarian cancer FIGO 4 study
2025
·
Halil Göksel Güzel
, Onur Yazdan Balçık
, et al.
·
American Journal of Obstetrics and Gynecology
·
1
Adjuvant Treatment Options and Modalities in Pancreatic Adenocarcinoma: Insights From ESPAC4
2025
·
Halil Göksel Güzel
, Arif Hakan Önder
·
Journal of Clinical Oncology
·
1
1271P Integrating machine learning prediction and causal inference analysis to unravel determinants of progression in EGFR-mutant, advanced NSCLC
2024
·
H. Bozcuk
, L. Sert
, et al.
·
Annals of Oncology
·
1
PDF
Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study
2026
·
Fatih Kus
, Fatih Atalah
, et al.
·
BMC Cancer
The Prognostic Significance of the NOLUS Score in Patients with Metastatic Breast Cancer Receiving CDK 4/6 Inhibitor Therapy
2026
·
Ece Ulukal Karancı
, Halil Göksel Güzel
, et al.
·
Acta Medica Alanya
PDF
Prognostic impact of the Gustave Roussy Immune score in metastatic renal cell carcinoma treated with first-line immunotherapy-based combinations: results from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)
2026
·
Aysun Fatma Akkuş
, Hatice Bölek
, et al.
·
BMC Cancer
Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group
2026
·
Mustafa Seyyar
, Pervin Can Şancı
, et al.
·
BMC Cancer
Does Social Media Use Associate with Vasomotor, Sexual, and Musculoskeletal Symptoms in Breast Cancer Survivors Receiving Endocrine Therapy?
2026
·
Halil Göksel Güzel
, Ece Ulukal Karancı
, et al.
·
Journal of Clinical Medicine
PDF
Prediction of pathological complete response after neoadjuvant treatment in triple negative breast cancer: a single center experience
2026
·
Ece Ulukal Karancı
, Halil Göksel Güzel
, et al.
·
Pamukkale Medical Journal
Bone Metastasis Distribution Matters: Prognostic Effect of the Axial‐to‐Peripheral Ratio in Metastatic Hormone‐Sensitive Prostate Cancer
2026
·
Ali Fuat Gürbüz
, Murat Araz
, et al.
·
The Prostate
Show more works
View as search
Works count:
41
Citation count:
46
H-index:
4
I10-index:
1
Year
Topic
Type